Menu
Surfing the MASH Tsunami
Podcast image
S3-E25.6 - Emerging Concepts In NASH: NAFLD Patient Screening, NASH Management
25 mins; May 22, 2022
S3-E25.5 - Emerging Concepts in NASH: Fatty Liver Pathophysiology, Epidemiology, Co-Morbidities
21 mins; May 22, 2022
S3-E25.4 - NASH Drug Development in 2022: Will Quality of Life Data Help NASH Drugs Over the Finish Line?
13 mins; May 22, 2022
S3-E25.3 - Future NASH Drug Development: More Diverse Trial Populations and More Study of Combination NASH Drugs
14 mins; May 21, 2022
S3-E25.2 - NASH Drug Development In 2022: A Wealth of Data and a Promising NASH Pipeline
14 mins; May 21, 2022
S3-E25.1 - NASH Drug Development in 2022: Late-Stage NASH Drugs and Their Path to Market
12 mins; May 21, 2022
S3-E25 - Crystal Ball Looks at Drug Development and the NASH Pipeline
100 hours 12 mins; May 18, 2022
S3-E24.5 - From #INCBCN: Digital Health and Patient Empowerment: a Conversation with Dr. Marcus Ranney
27 mins; May 15, 2022
3-E24.4 - Innovations in NAFLD Care Conference: What Is the Importance of Steatosis in Metabolic Health?
18 mins; May 15, 2022
S3-E24.3 - Stakeholder Diversity at the Innovations in NAFLD Care 2022 Conference: a Critical Success Factor
12 mins; May 15, 2022
S3-E24.2 - Controversy at the Innovations in NAFLD Care Conference: What Does Patient Empowerment Mean in Fatty Liver Disease?
15 mins; May 14, 2022
S3-E24.1 - Did the Innovations in NAFLD Care Conference Strengthen the Case for an Integrated NAFLD Care Pathway?
12 mins; May 14, 2022
S3-E24 - #INCBCN (Innovations in NAFLD Care 2022) Wrap-up plus Interview with Human Edge Founder Dr. Marcus Ranney
80 hours 30 mins; May 11, 2022
S3-E23.5 - How NAFLD Patient Advocacy Works: Two Key Pieces
12 mins; May 08, 2022
S3-E23.4 - How NAFLD Patient Advocacy Works: Targets and Opportunities for the Fatty Liver Community
13 mins; May 07, 2022
S3-E23.3 - How NAFLD Patient Advocacy Works: Disease Targets and Policy Successes in The Fatty Liver Community
13 mins; May 07, 2022
S3-E23.2 - How NAFLD Patient Advocacy Works: Targets and Opportunities for the Fatty Liver Community
13 mins; May 07, 2022
S3-E23.1 - NAFLD Patient Advocacy: Meet the Advocates And Hear Their Stories
13 mins; May 07, 2022
S3-E23 - So How Does NAFLD Patient Advocacy Support the Entire Fatty Liver Community?
66 hours 47 mins; May 04, 2022
S3-E22.4 - Previewing the 5th Global NASH Congress: Summing Up
13 mins; May 01, 2022
S3-E22.3 - Previewing the 5th Global NASH Congress: NASH Drug Development Presentations
12 mins; May 01, 2022
S3-E22.2 - Previewing the 5th Global NASH Congress: What can We Learn About Drugs in Development From Hepatic Cell Models and Advanced Omics?
13 mins; April 30, 2022
S3-E22.1 - Previewing the 5th Global NASH Congress: Gut Microbiome and Nutrition are the New Frontier
13 mins; April 30, 2022
S3-E22 - NASH Tsunami previews the 5th Global NASH Congress
55 mins; April 27, 2022
S3-E21.5 - NAFLD Provider education, NASH Patient Care and Digital Health
16 mins; April 24, 2022
S3-E21.4 - Donna Cryer Discusses NCQA on NASH Quality and the New GLI "Liver Health is Public Health" campaign
15 mins; April 24, 2022
S3-E21.3 - Digital Health and Behavioral Support apps in Future NASH Therapies
13 mins; April 23, 2022
S3-E21.2 - NAFLD Incidence in All Americans and The NASH-Diabetes Link
12 mins; April 23, 2022
S3-E21.1 - Challenges in NAFLD Care Delivery: Primary Care and NASH
12 mins; April 23, 2022
S3-E21 - Naim Alkhouri and Donna Cryer Bring News to Surfing the NASH Tsunami
62 hours 26 mins; April 20, 2022
S3-E20 - Jörn Schattenberg, Louise and Roger discuss NAFLD and SurfingNASH.com
35 mins; April 19, 2022
S3-E19.5 - NAIL-NIT: Expanding Vistas for Phase 1 Research
12 mins; April 17, 2022
S3-E19.4 - NAIL-NIT: "Morphic Resonance" and FDA Test Criteria
12 mins; April 17, 2022
S3-E19.3 - NAIL-NIT: What Naim Alkhouri and Jörn Schattenberg Plan for Retrospective Analysis
12 mins; April 16, 2022
S3 - E19.2 - Beginnings And Core Principles In The Move Beyond the Biopsy
10 mins; April 16, 2022
S3-E19.1 - Podcast News: SurfingNASH.com Is Here and a New Role for Jörn Schattenberg!
20 mins; April 16, 2022
3-E19 - What Can NAIL-NIT Retrospective Analysis Tell Us About NASH Clinical Trials?
65 hours 4 mins; April 13, 2022
S3-E18.4 - Previewing Innovations in NAFLD Care 2022: Day Two Sessions
12 mins; April 10, 2022
S3-E18.3 - Previewing Innovations in NAFLD Care 2022: SItes of Care and Organizing Patients
13 mins; April 10, 2022
S3-E18.2 - Previewing Innovations in NAFLD Care 2022: NASH Epidemiology
13 mins; April 09, 2022
S3-E18.1 - Why the Innovations in NAFLD Care Conference Came to Be
13 mins; April 09, 2022
S3-E18 - Previewing The Innovations In NAFLD Care 2022 Conference
54 mins; April 06, 2022
S3-E17.4 - What Can Single Cell Genomics Teach about Hepatic Regeneration?
13 mins; April 03, 2022
S3-E17.3 - Spatial Transcriptomics and The History of Single Cell Genomics
15 mins; April 03, 2022
S3-E17.2 - Future Targeted NASH Therapies and NASH Drug Development Today
14 mins; April 02, 2022
S3-E17.1 - Potential Breakthrough in Anti-Fibrotic Therapies Through mRNA/CAR-T Combined Therapies
15 mins; April 02, 2022
S3-E17 - New In NASH Science: CAR-T/mRNA Anti-Fibrotics and Advanced NASH omics
73 hours 48 mins; March 30, 2022
S3-E16.5 - Ready for "Prime Time?" - MRE and Hepatogram in NASH Clinical Practice
48 mins; March 27, 2022
S3-E16.4 - What a Disease Model Suggests about the NASH Diagnostic Path
15 mins; March 27, 2022
S3-E16.3 - What a Disease Model tells Us About NASH Patient Management
13 mins; March 27, 2022
S3-E16.2 - What a NASH Disease Model Reveals About Treating Advanced Fibrosis
14 mins; March 26, 2022
S3-E16.1 - Building a Disease Model for NASH Prevalence: Key Challenges
12 mins; March 26, 2022
S3-E16 - The Prospective Role of Data Modeling in Diagnostic and Drug Development
90 hours 43 mins; March 23, 2022
S3-E15.4 - CLDF Liver Connect program: How Well Did It Work?
20 mins; March 20, 2022
S3-E15.3 - From the 2022 Liver Conference: Pediatric NAFLD and Liver Health Education
12 mins; March 20, 2022
S3-E15.1 - An Interview with CLDF President Zobair Younossi about Liver Connect
25 mins; March 19, 2022
S3-E15.2 - Discussing Health Disparities at CLDF's NASH Connect Conference
14 mins; March 18, 2022
S3-E15 - Discussing NAFLD and NASH at CLDF's 2nd Annual Liver Connect
73 hours 38 mins; March 16, 2022
S3-E14.5 - Improving Ballooned Hepatocyte Analysis Through Artificial Intelligence
42 mins; March 14, 2022
S3-E14.4 - Ballooned Hepatocyte Analysis and Reassessing Drug Development
11 mins; March 13, 2022
S3-E14.3 - Systematic Flaws in Semi-Quantitative Ballooned Hepatocyte Analysis
13 mins; March 13, 2022
S3-E14.2 - Can We Manage Statistical Error in Ballooned Hepatocyte Analysis Better?
12 mins; March 12, 2022
S3-E14.1 - How Ballooned Hepatocyte Analytics Weaken NASH Clinical Trials
14 mins; March 12, 2022
S3-E14 - NAS Scores and the Challenge of Complex Ballooned Hepatocytes
94 hours 22 mins; March 09, 2022
S3-E13.4 - The NICE Draft Guidance vs. The Economics of NAFLD: Not a Great Fit
14 mins; March 06, 2022
S3-E13.3 - NICE Draft Guidance on NAFLD Screening: Long Term Issues
15 mins; March 06, 2022
S3-E13.2 - NICE Assesses FibroScan Screening: Health Economics & NAFLD
13 mins; March 05, 2022
S3-E13.1 - NICE Assesses FibroScan Community Screening: Analytic Tensions
16 mins; March 05, 2022
S3-E13 - Community Screening for NAFLD: What Must Advocates Prove?
66 hours 24 mins; March 02, 2022
S3 E12.4 - What Will Improve NASH Care For Black Americans Most and Fastest
13 mins; February 27, 2022
S3-E12.3 - The Need: Enrich Black America's NASH Clinical Trials Share
14 mins; February 27, 2022
S3-E12.2 - Why NASH Might Be Different For Black Americans: SDOH, Omics
15 mins; February 26, 2022
S3-E12.1 - NASH Care for Non-Hispanic Black Americans: The Issues and Why They Matter
12 mins; February 26, 2022
S3-E12 - Non-Hispanic Black Americans, SDOH and NASH
65 hours 49 mins; February 23, 2022
S3-E11.4 - NAIL-NIT: Retrospective Analysis, Then Prospective Studies
15 mins; February 20, 2022
S3-E11.3 - NAIL-NIT and the Challenges of the NAS Score
12 mins; February 20, 2022
S3-E11.2 - NAIL-NIT and the Challenges of Histopathology
12 mins; February 19, 2022
S3-E11.1 - NAIL-NIT: The Thinking Behind a New NAFLD Consortium
15 mins; February 19, 2022
S3-E11 - NAIL-NIT and the Path from Non-Invasive Testing To Outcomes
61 hours 13 mins; February 16, 2022
S3-E10.4 - Value of Screening for NAFLD as NASH Prevalence Grows
15 mins; February 13, 2022
S3-E10.3 - Value of Early NASH Diagnosis as NAFLD Prevalence Grows
12 mins; February 13, 2022
S3-E10.2 - What Does the SUNN Study Say About NASH Prevalence?
12 mins; February 12, 2022
S3-E10.1 - NAFLD and NASH Prevalence and Advanced Liver Fibrosis in Germany
15 mins; February 12, 2022
S3-E10 - Screening and Treatment Pathways in a World with High NAFLD Prevalence
61 hours 15 mins; February 09, 2022
S3-E9.4 - NASH Patient Care: The Value of Patient Education
21 mins; February 06, 2022
S3-E9.3 - NASH Patient Education: Liver Nurses' Roles
13 mins; February 06, 2022
S3-E9.2 - NASH Patient Support: Liver Nursing Challenges
15 mins; February 05, 2022
S3-E9.1 - NASH Patient Support: Meet Today's Liver Nurses
19 mins; February 05, 2022
S3-E9 - Are We Taking Full Advantage of the Skills and Knowledge that Liver Nurses and Advanced Nurse Practitioners Bring To NASH Education and Patient Care?
73 hours 4 mins; February 02, 2022
S3-E8.4 - SurfingNASH Discusses The Innovations In NAFLD Care 2022 Series With Jeff Lazarus And Jörn Schattenberg: Agenda Concepts
11 mins; January 30, 2022
S3-E8.3 - SurfingNASH Discusses The Innovations In NAFLD Care 2022 Series With Jeff Lazarus And Jörn Schattenberg: Structural Healthcare Issues
13 mins; January 30, 2022
S3-E8.2 - SurfingNASH discusses the Innovations in NAFLD Care 2022 Series with Jeff Lazarus and Jörn Schattenberg: Program Scope and Key Elements
15 mins; January 29, 2022
S3 E8.1 - SurfingNASH Discusses The Innovations In NAFLD Care 2022 Series With Jeff Lazarus And Jörn Schattenberg: Program Objectives
10 mins; January 29, 2022
S3-E8 - The "Innovations in NAFLD Care 2022" Series: Promoting the NAFLD Public Health Agenda
60 hours 5 mins; January 26, 2022
S3-E6 - Themes From NASH-TAG 2022: Insights on Combination Therapies
20 mins; January 22, 2022
S3-E5 - NASH-TAG 2022 bonus: A conversation with Donna Cryer and Scott Friedman
49 mins; January 20, 2022
S3-E4.4 - NASH-TAG 2022 Wrap-up: Improving Cost Efficiency of NASH Trials By Reducing Screen Fail Rates
15 mins; January 16, 2022
S3-E4.3 - NASH-TAG 2022 Wrap-up: NITs from The FDA and Patients' Perspectives
15 mins; January 16, 2022
S3-E4.2 - NASH-TAG 2022 Wrap-up: The Fireside Chat and the Changing Paradigm For NASH Diagnostics
12 mins; January 15, 2022
S3-E4.1 - NASH-TAG 2022 Wrap-up: High Impact presentations
18 mins; January 15, 2022
Click here to see more
Useful pages

Apply to teach

Reviews

Help & FAQs

Blog

Spanish Podcast

French Podcast

Italian Podcast

About Us

Contact Us

Terms & Privacy

Find a tutor

Arabic tutors

Chinese tutors

Dutch tutors

English tutors

French tutors

German tutors

Greek tutors

Italian tutors

Japanese tutors

Korean tutors

Portuguese tutors

Romanian tutors

Russian tutors

Spanish tutors

Swedish tutors

Thai tutors

More languages soon!

Languages

Learn Arabic

Learn Chinese

Learn Dutch

Learn English

Learn French

Learn German

Learn Greek

Learn Italian

Learn Japanese

Learn Korean

Learn Portuguese

Learn Romanian

Learn Russian

Learn Spanish

Learn Swedish

Learn Thai

© 2026 LanguaTalk, All Rights Reserved